Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Materialise NV is a software—application business based in the US. Materialise shares (MTLS) are listed on the NASDAQ and all prices are listed in US Dollars. Materialise employs 2,177 staff and has a market cap (total outstanding shares value) of USD$2.6 billion.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Latest market close | USD$46.86 |
---|---|
52-week range | USD$10.65 - USD$52.87 |
50-day moving average | USD$40.3646 |
200-day moving average | USD$28.3283 |
Wall St. target price | USD$16.51 |
PE ratio | 597.2395 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$0.097 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $46.86 from 2020-12-18
1 week (2021-01-08) | -33.44% |
---|---|
1 month (2020-12-15) | 5.71% |
3 months (2020-10-15) | -6.73% |
6 months (2020-07-15) | 83.48% |
1 year (2020-01-15) | 146.50% |
---|---|
2 years (2019-01-15) | 139.94% |
3 years (2018-01-12) | 240.06% |
5 years (2016-01-15) | 677.11% |
Valuing Materialise stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Materialise's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Materialise's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 597x. In other words, Materialise shares trade at around 597x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Gross profit TTM | USD$109.7 million |
---|---|
Return on assets TTM | 0.54% |
Return on equity TTM | -1.83% |
Profit margin | -1.31% |
Book value | $3.05 |
Market capitalisation | USD$2.6 billion |
TTM: trailing 12 months
There are currently 1.2 million Materialise shares held short by investors – that's known as Materialise's "short interest". This figure is 19.8% up from 1.0 million last month.
There are a few different ways that this level of interest in shorting Materialise shares can be evaluated.
Materialise's "short interest ratio" (SIR) is the quantity of Materialise shares currently shorted divided by the average quantity of Materialise shares traded daily (recently around 235903.14341847). Materialise's SIR currently stands at 5.09. In other words for every 100,000 Materialise shares traded daily on the market, roughly 5090 shares are currently held short.
However Materialise's short interest can also be evaluated against the total number of Materialise shares, or, against the total number of tradable Materialise shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Materialise's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Materialise shares in existence, roughly 20 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Materialise shares, roughly 0 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Materialise.
Find out more about how you can short Materialise stock.
We're not expecting Materialise to pay a dividend over the next 12 months.
Over the last 12 months, Materialise's shares have ranged in value from as little as $10.65 up to $52.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Materialise's is 0.7711. This would suggest that Materialise's shares are less volatile than average (for this exchange).
Materialise NV provides additive manufacturing and medical software, and 3D printing services in Europe, the Americas, Europe and Africa, and the Asia-Pacific. The company's Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design packages and 3D scanners. This segment serves 3D printing machine original equipment manufacturers; manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. Its Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The company's Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. It has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Global Orthopaedic Technology Pty Ltd; Limacorporate Spa; Mathys AG; Howmedica Osteonics Corp.; Corin Ltd.; and Fluidda, as well as a partnership with Sigma Labs, Inc. The company was founded in 1990 and is headquartered in Leuven, Belgium.
Steps to owning and managing DRIO, with 24-hour and historical pricing before you buy.
Steps to owning and managing CYBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing CHCI, with 24-hour and historical pricing before you buy.
Steps to owning and managing CIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing CKX, with 24-hour and historical pricing before you buy.
Steps to owning and managing CHA, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTHR, with 24-hour and historical pricing before you buy.
Steps to owning and managing CNBKA, with 24-hour and historical pricing before you buy.
Steps to owning and managing CATM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRME, with 24-hour and historical pricing before you buy.